Morpholines
Concept
Vocabulary Service
Overview
subject area of
-
A Phase I Evaluation of Oral CI-1033 in Combination with Paclitaxel and Carboplatin as First-Line Chemotherapy in Patients with Advanced Non-small Cell Lung Cancer Academic Article
-
A Replacement for Warfarin Academic Article
-
A logical approach to surgical thromboprophylaxis Academic Article
-
A non-interventional comparison of rivaroxaban with standard of care for thromboprophylaxis after major orthopaedic surgery in 17,701 patients with propensity score adjustment Academic Article
-
Acute management of bleeding in patients on novel oral anticoagulants Academic Article
-
Adropin Is a Novel Regulator of Endothelial Function Conference Paper
-
Advances in the management of venous thromboembolism Academic Article
-
Advances in the management of venous thromboembolism. Academic Article
-
Advantages and limitations of the new anticoagulants Academic Article
-
After PCI with stents for AF, adding rivaroxaban vs warfarin to antiplatelet drugs reduced bleeding Academic Article
-
An Open Trial of Reboxetine in HIV-Seropositive Outpatients With Major Depressive Disorder Academic Article
-
An open trial of reboxetine in obese patients with binge eating disorder Academic Article
-
Anti-pneumococcal deficits of monocyte-derived macrophages from the advanced-age, frail elderly and related impairments in PI3K-AKT signaling Academic Article
-
Approach to the new oral anticoagulants in family practice: part 1: comparing the options. Academic Article
-
Approach to the new oral anticoagulants in family practice: part 2: addressing frequently asked questions. Academic Article
-
Assays for Measuring Rivaroxaban: Their Suitability and Limitations Academic Article
-
BAY 59-7939: an oral, direct Factor Xa inhibitor for the prevention of venous thromboembolism in patients after total knee replacement. A phase II dose-ranging study Academic Article
-
Balancing risk and benefit in venous thromboembolism trials: concept for a bivariate endpoint trial design and analytic approach Academic Article
-
Benefit–risk assessment of rivaroxaban versus enoxaparin for the prevention of venous thromboembolism after total hip or knee arthroplasty Academic Article
-
Beyond Unfractionated Heparin and Warfarin Academic Article
-
Bleeding and antidotes in new oral anticoagulants Academic Article
-
Cannabinoid WIN55212‐2 impairs peanut‐allergic sensitization and promotes the generation of allergen‐specific regulatory T cells Academic Article
-
Clinical review: Clinical management of new oral anticoagulants: a structured review with emphasis on the reversal of bleeding complications Academic Article
-
Comparative Pharmacodynamics and Pharmacokinetics of Oral Direct Thrombin and Factor Xa Inhibitors in Development Academic Article
-
Comparative effectiveness and safety of the novel oral anticoagulants: do the pivotal clinical trials point to a new paradigm? Academic Article
-
Comparison of the effects of apixaban and rivaroxaban on prothrombin and activated partial thromboplastin times using various reagents Academic Article
-
Comparison of three‐factor and four‐factor prothrombin complex concentrates regarding reversal of the anticoagulant effects of rivaroxaban in healthy volunteers Academic Article
-
Cost-effectiveness of Dabigatran and Rivaroxaban Compared with Warfarin for Stroke Prevention in Patients with Atrial Fibrillation Academic Article
-
Dabigatran versus rivaroxaban for the prevention of stroke and systemic embolism in atrial fibrillation in Canada Academic Article
-
Design of the rivaroxaban for heparin-induced thrombocytopenia study Academic Article
-
Developmental effects of the industrial cooling water additives morpholine and sodium hypochlorite on lake whitefish (Coregonus clupeaformis) Academic Article
-
Direct oral anticoagulants compared with vitamin K antagonists for acute venous thromboembolism: evidence from phase 3 trials Academic Article
-
Direct oral anticoagulants compared with vitamin K antagonists for acute venous thromboembolism: evidence from phase 3 trials. Academic Article
-
Effect in vitro on platelet function of two compounds developed from the pyrimido-pyrimidines Academic Article
-
Enoxaparin Versus Dabigatran or Rivaroxaban for Thromboprophylaxis After Hip or Knee Arthroplasty Academic Article
-
Evolving use of new oral anticoagulants for treatment of venous thromboembolism Academic Article
-
Factor Xa and thrombin as targets for new oral anticoagulants Academic Article
-
Fostamatinib for the treatment of adult persistent and chronic immune thrombocytopenia: Results of two phase 3, randomized, placebo‐controlled trials Academic Article
-
Fostamatinib for the treatment of warm antibody autoimmune hemolytic anemia: Phase 2, multicenter, open‐label study Academic Article
-
Gastrointestinal bleeding with the new oral anticoagulants – defining the issues and the management strategies Academic Article
-
Genome-based taxonomic framework for the class Negativicutes: division of the class Negativicutes into the orders Selenomonadales emend., Acidaminococcales ord. nov. and Veillonellales ord. nov. Academic Article
-
Guanosine Protects Glial Cells Against 6-Hydroxydopamine Toxicity Academic Article
-
Guanosine protects SH-SY5Y cells against β-amyloid-induced apoptosis Academic Article
-
How I treat target-specific oral anticoagulant–associated bleeding Academic Article
-
Impacts of temperature, morpholine, and chronic radiation on the embryonic development of round whitefish (Prosopium cylindraceum) Academic Article
-
Insulin increases FA uptake and esterification but reduces lipid utilization in isolated contracting muscle Academic Article
-
Interleukins 4 and 13 Increase Intestinal Epithelial Permeability by a Phosphatidylinositol 3-Kinase Pathway Academic Article
-
Ionizing Radiation Activates AMP-Activated Kinase (AMPK): A Target for Radiosensitization of Human Cancer Cells Academic Article
-
Is there a role for the novel oral anticoagulants in patients with an acute coronary syndrome? A review of the clinical trials Academic Article
-
Laboratory Measurement of the Anticoagulant Activity of the Non–Vitamin K Oral Anticoagulants Academic Article
-
Long‐term fostamatinib treatment of adults with immune thrombocytopenia during the phase 3 clinical trial program Academic Article
-
Management consensus guidance for the use of rivaroxaban – an oral, direct factor Xa inhibitor Academic Article
-
Managing New Oral Anticoagulants in the Perioperative and Intensive Care Unit Setting Academic Article
-
Micronuclei formation in rainbow trout cells exposed to multiple stressors: Morpholine, heat shock, and ionizing radiation Academic Article
-
Monitoring the anticoagulant effect after a massive rivaroxaban overdose Academic Article
-
New Anticoagulants for Atrial Fibrillation Academic Article
-
New Anticoagulants for Treatment of Venous Thromboembolism Academic Article
-
New Anticoagulants for the Prevention of Thromboembolism Academic Article
-
New Antithrombotic Drugs: Potential for Use in Oncology Academic Article
-
New oral anticoagulant agents – general features and outcomes in subsets of patients Academic Article
-
New oral anticoagulants and oculoplastic surgery Academic Article
-
New oral anticoagulants for stroke prevention in atrial fibrillation: impact of study design, double counting and unexpected findings on interpretation of study results and conclusions Academic Article
-
New oral anticoagulants for thromboprophylaxis in patients having hip or knee arthroplasty Academic Article
-
New oral anticoagulants in elderly patients Academic Article
-
New oral anticoagulants: not quite there yet Academic Article
-
New oral anticoagulants: which one should my patient use? Academic Article
-
Novel Oral Anticoagulants: A Focused Review for Stroke Physicians Academic Article
-
Novel Oral Factor Xa and Thrombin Inhibitors in the Management of Thromboembolism Academic Article
-
Novel oral anticoagulants in gastroenterology practice Academic Article
-
Novel oral anticoagulants in secondary prevention of stroke Academic Article
-
Oncostatin M induction of eotaxin-1 expression requires the convergence of PI3′K and ERK1/2 MAPK signal transduction pathways Academic Article
-
Oral Anticoagulant Therapy Academic Article
-
Oral Rivaroxaban for Symptomatic Venous Thromboembolism Academic Article
-
Oral Rivaroxaban for the Treatment of Symptomatic Pulmonary Embolism Academic Article
-
Oral anticoagulant use in addition to antiplatelet therapy for secondary prevention in acute coronary syndrome: current perspectives Academic Article
-
Oral rivaroxaban for the prevention of symptomatic venous thromboembolism after elective hip and knee replacement Academic Article
-
Oral, Direct Factor Xa Inhibitors in Development for the Prevention and Treatment of Thromboembolic Diseases Academic Article
-
Outcomes of Temporary Interruption of Rivaroxaban Compared With Warfarin in Patients With Nonvalvular Atrial Fibrillation Academic Article
-
Overview of the New Oral Anticoagulants Academic Article
-
Panax quinquefolium saponin combined with dual antiplatelet drugs inhibits platelet adhesion to injured HUVECs via PI3K/AKT and COX pathways Academic Article
-
Perioperative management of patients who are receiving a novel oral anticoagulant Academic Article
-
Periprocedural antithrombotic and bridging therapy: recommendations for standardized reporting in patients with arterial indications for chronic oral anticoagulant therapy Academic Article
-
Pharmacologic Properties of the New Oral Anticoagulants: A Clinician-oriented Review with a Focus on Perioperative Management Academic Article
-
Physiological evidence of a postsynaptic inhibition of the tail flick reflex by a cannabinoid receptor agonist Academic Article
-
Pinaverium acts as L-type calcium channel blocker on smooth muscle of colon Academic Article
-
Population Pharmacokinetics and Pharmacodynamics of Rivaroxaban – an Oral, Direct Factor Xa Inhibitor – in Patients Undergoing Major Orthopaedic Surgery Academic Article
-
Potent enantioselective inhibition of DNA-dependent protein kinase (DNA-PK) by atropisomeric chromenone derivatives Academic Article
-
Potential of new anticoagulants in patients with cancer Academic Article
-
Practical aspects of new oral anticoagulant use in atrial fibrillation Academic Article
-
Practical guidance for using rivaroxaban in patients with atrial fibrillation: balancing benefit and risk Academic Article
-
Practical management of bleeding due to the anticoagulants dabigatran, rivaroxaban, and apixaban Academic Article
-
Procoagulants for management of bleeding with the new oral anticoagulants Academic Article
-
Prokinetics for functional dyspepsia Academic Article
-
Rationale and design of XAMOS: noninterventional study of rivaroxaban for prophylaxis of venous thromboembolism after major hip and knee surgery Academic Article
-
Reduced-Intensity Rivaroxaban for the Prevention of Recurrent Venous Thromboembolism Academic Article
-
Report of the Subcommittee of Control of Anticoagulation on the determination of the anticoagulant effects of rivaroxaban Academic Article
-
Response to “Role of Orally Available Antagonists of Factor Xa in the Treatment and Prevention of Thromboembolic Disease: Focus on Rivaroxaban” Academic Article
-
Response. Academic Article
-
Risk Stratification and Stroke Prevention Therapy Care Gaps in Canadian Atrial Fibrillation Patients (from the Co-ordinated National Network to Engage Physicians in the Care and Treatment of Patients With Atrial Fibrillation Chart Audit) Academic Article
-
Rivaroxaban for stroke prevention in atrial fibrillation: a critical review of the ROCKET AF trial Academic Article
-
Rivaroxaban for the prevention and treatment of venous thromboembolism Academic Article
-
Rivaroxaban for the prevention of venous thromboembolism after hip or knee arthroplasty Academic Article
-
Rivaroxaban for thromboprophylaxis after orthopaedic surgery: Pooled analysis of two studies Academic Article
-
Rivaroxaban for treatment of HIT: A riveting first experience Academic Article
-
Rivaroxaban in Orthopedic Surgery — A Change of Paradigm? Academic Article
-
Rivaroxaban versus Enoxaparin for Thromboprophylaxis after Total Knee Arthroplasty Academic Article
-
Rivaroxaban versus enoxaparin after total knee arthroplasty Academic Article
-
Rivaroxaban versus enoxaparin for thromboprophylaxis after total knee arthroplasty (RECORD4): a randomised trial Academic Article
-
Rivaroxaban vs. low molecular weight heparin for the prevention of venous thromboembolism after hip or knee arthroplasty: a cohort study Academic Article
-
Role of sphingolipids in the transport of prosaposin to the lysosomes Academic Article
-
Selective factor Xa inhibition for thromboprophylaxis Academic Article
-
Shear flow-induced motility ofDictyostelium discoideumcells on solid substrate Academic Article
-
Suicidal Ideation and Behavior in Adolescents Aged 12-16 Years: A 17-Year Follow-Up Academic Article
-
Superantigen immune stimulation activates epithelial STAT-1 and PI 3-K: PI 3-K regulation of permeability Academic Article
-
The arotinoids: early clinical experience and discussion of future development. Academic Article
-
The arotinoids: early clinical experience and discussion of future development. Academic Article
-
The effects of rivaroxaban on the complications of surgery after total hip or knee replacement Academic Article
-
The top 4 advances in antithrombotic care in the last year Academic Article
-
Therapeutic Potential of Spleen Tyrosine Kinase Inhibition for Treating High-Risk Precursor B Cell Acute Lymphoblastic Leukemia Academic Article
-
Transition from apixaban to warfarin—addressing excess stroke, systemic embolism, and major bleeding Academic Article
-
Treatment of venous thromboembolism with dabigatran Academic Article
-
USP22 mediates the multidrug resistance of hepatocellular carcinoma via the SIRT1/AKT/MRP1 signaling pathway Academic Article
-
Ultrasound screening for asymptomatic deep vein thrombosis after major orthopaedic surgery: the VENUS study Academic Article
-
Venous thromboembolism management: where do novel anticoagulants fit? Academic Article
-
Well-managed warfarin is superior to NOACs Response Academic Article
-
What is the effect of rivaroxaban on routine coagulation tests? Academic Article
-
XANTUS: rationale and design of a noninterventional study of rivaroxaban for the prevention of stroke in patients with atrial fibrillation Academic Article